MSC-话题@MedSci

#MSC#

87篇内容 | 1415人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1406675, encodeId=c8bd14066e5de, content=<a href='/topic/show?id=099d122e1cd' target=_blank style='color:#2F92EE;'>#MSC#</a>, objectTitle=招募患者：MSC2156119J对比索拉非尼治疗晚期肝细胞癌受试者的有效性、安全性和PK的多中心、随机、Ib联合II期临床试验, objectType=article, longId=56011, objectId=342c560114a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=342c560114a, replyNumber=0, likeNumber=32, createdTime=2015-09-11, rootId=0, userName=huanbaofeng, userId=55e02571190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=342c560114a, moduleTitle=招募患者：MSC2156119J对比索拉非尼治疗晚期肝细胞癌受试者的有效性、安全性和PK的多中心、随机、Ib联合II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=342c560114a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406674, encodeId=273214066e4f6, content=<a href='/topic/show?id=099d122e1cd' target=_blank style='color:#2F92EE;'>#MSC#</a>, objectTitle=ASCO 2014：MSC2156119J+吉非替尼治疗MET阳性EGFR突变晚期NSCLC的I/II期临床试验, objectType=article, longId=35667, objectId=f1cf3566e12, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1cf3566e12, replyNumber=0, likeNumber=30, createdTime=2014-06-02, rootId=0, userName=huanbaofeng, userId=55e02571190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1cf3566e12, moduleTitle=ASCO 2014：MSC2156119J+吉非替尼治疗MET阳性EGFR突变晚期NSCLC的I/II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1cf3566e12)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406673, encodeId=f12914066e341, content=<a href='/topic/show?id=099d122e1cd' target=_blank style='color:#2F92EE;'>#MSC#</a>, objectTitle=ASCO 2014：亚洲进展期肝癌患者口服c-Met抑制剂MSC2156119J单药与索拉非尼比较的Ib/II期试验, objectType=article, longId=35648, objectId=35c7356487a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35c7356487a, replyNumber=0, likeNumber=32, createdTime=2014-06-02, rootId=0, userName=huanbaofeng, userId=55e02571190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35c7356487a, moduleTitle=ASCO 2014：亚洲进展期肝癌患者口服c-Met抑制剂MSC2156119J单药与索拉非尼比较的Ib/II期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35c7356487a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406672, encodeId=0e1f14066e202, content=<a href='/topic/show?id=099d122e1cd' target=_blank style='color:#2F92EE;'>#MSC#</a>, objectTitle=Heart:MSCT和IVUS评估支架内情况一致性良好, objectType=article, longId=19680, objectId=501319680b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=501319680b2, replyNumber=0, likeNumber=30, createdTime=2013-06-06, rootId=0, userName=huanbaofeng, userId=55e02571190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=501319680b2, moduleTitle=Heart:MSCT和IVUS评估支架内情况一致性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=501319680b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406671, encodeId=f4a014066e152, content=<a href='/topic/show?id=099d122e1cd' target=_blank style='color:#2F92EE;'>#MSC#</a>, objectTitle=《消化内镜多学科镇静课程》(MSCGE), objectType=article, longId=7891, objectId=fee4e891ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fee4e891ea, replyNumber=0, likeNumber=31, createdTime=2012-07-18, rootId=0, userName=huanbaofeng, userId=55e02571190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fee4e891ea, moduleTitle=《消化内镜多学科镇静课程》(MSCGE), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fee4e891ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406670, encodeId=b7da14066e0db, content=<a href='/topic/show?id=099d122e1cd' target=_blank style='color:#2F92EE;'>#MSC#</a>, objectTitle=多排CT（multidetector CT, MDCT)和多层CT（multi-slice CT, MSCT)的区别, objectType=article, longId=5884, objectId=1e7b588455, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e7b588455, replyNumber=0, likeNumber=39, createdTime=2012-05-01, rootId=0, userName=huanbaofeng, userId=55e02571190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e7b588455, moduleTitle=多排CT（multidetector CT, MDCT)和多层CT（multi-slice CT, MSCT)的区别, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e7b588455)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406669, encodeId=9686140666923, content=<a href='/topic/show?id=099d122e1cd' target=_blank style='color:#2F92EE;'>#MSC#</a>, objectTitle=DRCP: 治疗DM足BMMSC更优, objectType=article, longId=2712, objectId=c58f2e121c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c58f2e121c, replyNumber=0, likeNumber=0, createdTime=2011-06-15, rootId=0, userName=huanbaofeng, userId=55e02571190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c58f2e121c, moduleTitle=DRCP: 治疗DM足BMMSC更优, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c58f2e121c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MSC

2020-05-29

huanbaofeng (审核中...)

前往app查看评论内容

#MSC#

招募患者：MSC2156119J对比索拉非尼治疗晚期肝细胞癌受试者的有效性、安全性和PK的多中心、随机、Ib联合II期临床试验

2015-09-11

huanbaofeng (审核中...)

前往app查看评论内容

#MSC#

ASCO 2014：MSC2156119J+吉非替尼治疗MET阳性EGFR突变晚期NSCLC的I/II期临床试验

2014-06-02

huanbaofeng (审核中...)

前往app查看评论内容

#MSC#

ASCO 2014：亚洲进展期肝癌患者口服c-Met抑制剂MSC2156119J单药与索拉非尼比较的Ib/II期试验

2014-06-02

huanbaofeng (审核中...)

前往app查看评论内容

#MSC#

Heart:MSCT和IVUS评估支架内情况一致性良好

2013-06-06

huanbaofeng (审核中...)

前往app查看评论内容

#MSC#

《消化内镜多学科镇静课程》(MSCGE)

2012-07-18

huanbaofeng (审核中...)

前往app查看评论内容

#MSC#

多排CT（multidetector CT, MDCT)和多层CT（multi-slice CT, MSCT)的区别

2012-05-01

huanbaofeng (审核中...)

前往app查看评论内容

#MSC#

DRCP: 治疗DM足BMMSC更优

2011-06-15

科室
- - 订阅+
  - 更多科室
工具
服务